Matches in SemOpenAlex for { <https://semopenalex.org/work/W2954508708> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2954508708 abstract "Objective(s). Interferon alpha therapy is associated with series of adverse effects leading premature discontinuation of treatment. Here we aimed to determine the effects of Tumor necrosis alpha promoter polymorphisms on interferon related side effects during interferon alpha 2b treatment in chronic hepatitis B patients
 Material and Method(s). This observational study enrolled 50 chronic hepatitis B patients, who were treated with interferon alpha 2b 10 tiw plus lamivudine 100mg/day at Selçuk University Meram Medical Faculty Department of Infectious Diseases and Clinical Bacteriology between 2006-2007. Patients were followed-up with complete blood count, transaminases and amylase monthly at out patient clinics of our department. All patients were asked to fill a questionnaire to evaluate the interferon related side effects at every visit. Tumor necrosis factor alpha -238 and -308 polymorphisms were investigated with PCR-Restriction fragment length polymorphisms.
 Result(s) and Conclusion Arthralgia was present in 93.8% of patients. Exhaustion, loss of appetite, mount dryness and fever are the leading complaints of the patients. Median complaint scores were 9, 9.5, 11 and 5 at 4th, 12th, 24th and 48th week visits, respectively. Thrombocytopenia and leucopenia were detected in 8 (16%) and 5 (10%) patients, respectively. One-third of the patients reported depressive mood however, depression was diagnosed in 5 (10%) patients. TNF alpha promoter 238GG and 308GG allele was present in 42/50 and 43/50 patients, respectively. No association was found between TNF promoter allele and certain patient-reported side effect, complaint score, hematological and psychological adverse effects. TNF alpha promoter polymorphisms do not contribute to occurrence of IFN alpha treatment related side effects." @default.
- W2954508708 created "2019-07-12" @default.
- W2954508708 creator A5014473342 @default.
- W2954508708 creator A5018122941 @default.
- W2954508708 creator A5052400916 @default.
- W2954508708 creator A5077614072 @default.
- W2954508708 creator A5086535270 @default.
- W2954508708 date "2019-06-30" @default.
- W2954508708 modified "2023-09-26" @default.
- W2954508708 title "Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment" @default.
- W2954508708 cites W2031178654 @default.
- W2954508708 cites W2038697192 @default.
- W2954508708 cites W2042329639 @default.
- W2954508708 cites W2061542205 @default.
- W2954508708 cites W2087564721 @default.
- W2954508708 cites W2090852043 @default.
- W2954508708 cites W2097747927 @default.
- W2954508708 cites W2110277154 @default.
- W2954508708 cites W2142395532 @default.
- W2954508708 cites W2579544732 @default.
- W2954508708 cites W2737702501 @default.
- W2954508708 cites W2807177518 @default.
- W2954508708 cites W2934698439 @default.
- W2954508708 doi "https://doi.org/10.32552/2019.actamedica.345" @default.
- W2954508708 hasPublicationYear "2019" @default.
- W2954508708 type Work @default.
- W2954508708 sameAs 2954508708 @default.
- W2954508708 citedByCount "1" @default.
- W2954508708 countsByYear W29545087082020 @default.
- W2954508708 crossrefType "journal-article" @default.
- W2954508708 hasAuthorship W2954508708A5014473342 @default.
- W2954508708 hasAuthorship W2954508708A5018122941 @default.
- W2954508708 hasAuthorship W2954508708A5052400916 @default.
- W2954508708 hasAuthorship W2954508708A5077614072 @default.
- W2954508708 hasAuthorship W2954508708A5086535270 @default.
- W2954508708 hasBestOaLocation W29545087081 @default.
- W2954508708 hasConcept C126322002 @default.
- W2954508708 hasConcept C17991360 @default.
- W2954508708 hasConcept C197934379 @default.
- W2954508708 hasConcept C203014093 @default.
- W2954508708 hasConcept C2776178377 @default.
- W2954508708 hasConcept C2778715236 @default.
- W2954508708 hasConcept C2909179924 @default.
- W2954508708 hasConcept C71924100 @default.
- W2954508708 hasConcept C90924648 @default.
- W2954508708 hasConceptScore W2954508708C126322002 @default.
- W2954508708 hasConceptScore W2954508708C17991360 @default.
- W2954508708 hasConceptScore W2954508708C197934379 @default.
- W2954508708 hasConceptScore W2954508708C203014093 @default.
- W2954508708 hasConceptScore W2954508708C2776178377 @default.
- W2954508708 hasConceptScore W2954508708C2778715236 @default.
- W2954508708 hasConceptScore W2954508708C2909179924 @default.
- W2954508708 hasConceptScore W2954508708C71924100 @default.
- W2954508708 hasConceptScore W2954508708C90924648 @default.
- W2954508708 hasLocation W29545087081 @default.
- W2954508708 hasOpenAccess W2954508708 @default.
- W2954508708 hasPrimaryLocation W29545087081 @default.
- W2954508708 hasRelatedWork W2022051943 @default.
- W2954508708 hasRelatedWork W2023856208 @default.
- W2954508708 hasRelatedWork W2066268125 @default.
- W2954508708 hasRelatedWork W2075737026 @default.
- W2954508708 hasRelatedWork W2077990172 @default.
- W2954508708 hasRelatedWork W2085691419 @default.
- W2954508708 hasRelatedWork W2111409974 @default.
- W2954508708 hasRelatedWork W2124074233 @default.
- W2954508708 hasRelatedWork W2135665034 @default.
- W2954508708 hasRelatedWork W2182413572 @default.
- W2954508708 hasRelatedWork W237578371 @default.
- W2954508708 hasRelatedWork W2397619008 @default.
- W2954508708 hasRelatedWork W2440379972 @default.
- W2954508708 hasRelatedWork W2466317404 @default.
- W2954508708 hasRelatedWork W2588846415 @default.
- W2954508708 hasRelatedWork W287993582 @default.
- W2954508708 hasRelatedWork W2996286150 @default.
- W2954508708 hasRelatedWork W3013431303 @default.
- W2954508708 hasRelatedWork W3156145723 @default.
- W2954508708 hasRelatedWork W842656664 @default.
- W2954508708 isParatext "false" @default.
- W2954508708 isRetracted "false" @default.
- W2954508708 magId "2954508708" @default.
- W2954508708 workType "article" @default.